Soligenix
SNGX
#10882
Rank
โ‚น0.52 B
Marketcap
โ‚น35.67
Share price
-0.29%
Change (1 day)
-85.08%
Change (1 year)

Soligenix (SNGX) - Total debt

Total debt on the balance sheet as of March 2026 : โ‚น31.54 Million

According to Soligenix's latest financial reports the company's total debt is โ‚น31.54 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Soligenix - Total debt on balance sheet (from 1998 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚น32.15 M-74.76%
2024-12-31โ‚น0.12 B-56.22%
2023-12-31โ‚น0.29 B-65.67%
2022-12-31โ‚น0.84 B14.28%
2021-12-31โ‚น0.74 B-3.49%
2020-12-31โ‚น0.76 B8369.11%
2019-12-31โ‚น9.07 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31โ‚น19.45 M-91.9%
2014-12-31โ‚น0.24 B-53.06%
2013-12-31โ‚น0.51 B
2004-12-31โ‚น5.02 M-69.28%
2003-12-31โ‚น16.34 M-53.3%
2002-12-31โ‚น35 M234.56%
2001-12-31โ‚น10.46 M-30.58%
2000-12-31โ‚น15.07 M-11.61%
1999-12-31โ‚น17.05 M0.26%
1998-12-31โ‚น17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚น5.245 T 16,629,368.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น6.079 T 19,273,474.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น2.210 T 7,007,914.27%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น1.77 B 5,518.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.612 T 5,113,007.12%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น54.71 B 173,371.24%๐Ÿ‡บ๐Ÿ‡ธ USA